Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Finasteride reduces hair growth and is safe for women with excessive hair.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

Baicalin may help reduce excessive male hormone levels in PCOS.

Human hair follicles can make and process prostaglandins, which may affect hair growth.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

Post-finasteride syndrome's existence is uncertain; more research needed.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Hair care products with placental growth factor can improve hair thickness and density in postpartum hair loss.

Acne is an important sign of androgen excess disorders in women.